Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I–III breast cancer who were treated w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Brewster, Abenaa M., Hortobagyi, Gabriel N., Broglio, Kristine R., Kau, Shu-Wan, Santa-Maria, Cesar A., Arun, Banu, Buzdar, Aman U., Booser, Daniel J., Valero, Vincente, Bondy, Melissa, Esteva, Francisco J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2008
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6592411/
https://ncbi.nlm.nih.gov/pubmed/18695137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados